Page 21 - ஒசிலோ பல்கலைக்கழகம் மருத்துவமனை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Apr 14, 2021 TUESDAY, April 13, 2021 (HealthDay News) While rare, thrombosis and thrombocytopenia can occur after the ChAdOx1 nCoV-19 adenoviral vector vaccine against COVID-19 (AstraZeneca), according to two reports published online April 9 in the New England Journal of Medicine. Andreas Greinacher, M.D., from Universitätsmedizin Greifswald in Germany, and colleagues assessed the clinical and laboratory features of 11 patients (nine women; median age, 36 years) in Germany and Austria experiencing thrombosis or thrombocytopenia after vaccination with ChAdOx1 nCov-19. Thrombotic events occurred five to 16 days after vaccination in all except one patient, and six of these patients died. The researchers conclude that vaccination can result in the rare development of immune thrombotic thrombocytopenia mediated by platelet-activating antibodies against platelet factor 4 (PF4), which clinically mimics autoimmune heparin-induced thrombocytopenia.

Mecklenburg vorpommernAndreas greinacherNinah schultzOslo university hospitalHealthday newsNew england journalமெக்லென்பர்க் வோர்பொம்மேர்ன்ஒசிலோ பல்கலைக்கழகம் மருத்துவமனைபுதியது இங்கிலாந்து இதழ்